Pineal glands obtained from rats of different ages were incubated in vitro with drugs known to specifically alter pre- or postsynaptic noradrenergic neurotransmission to determine when during development nerve terminal or receptor mediated control of glandular N-acetyltransferase (NAT) activity might reach functional maturation. Basal daytime NAT activity measured in vitro was lowest in fetal rats, increased dramatically by the day of birth, peaked at 10 days postnatally, and subsequently declined to near adult levels by 25 days of age. Drugs (isoproterenol, norepinephrine, or propranolol) known to influence pineal gland NAT activity by acting directly on pinealocyte postsynaptic beta-noradrenoceptors produced comparable changes in enzyme activity at all ages studied, although larger doses of the receptor agonist were required in fetal animals to elevate NAT activity. In contrast, in vitro incubation with indirect acting drugs (amphetamine or 1-dopa) which require functional presynaptic nerve terminals to exert their pharmacological effects, failed to increase pineal gland NAT activity until early in postnatal life. Hence, postsynaptic beta-noradrenoceptors may function to control pineal gland NAT activity prior to the time when the presynaptic sympathetic neurons innervating the gland attain maturational status.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.